Breatheamerica Albuquerque, INC.

Breatheamerica Albuquerque, INC. was paid $4.19M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 95165, Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials — 30% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	12,979	$634K
2019	12,848	$693K
2020	9,622	$505K
2021	10,205	$439K
2022	12,410	$537K
2023	14,415	$667K
2024incomplete	12,318	$713K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	30%	5,188	5,078	$1.28M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	14%	6,445	6,304	$588K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	12%	3,484	3,430	$503K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	10%	2,844	2,827	$420K
95117		9.4%	42,544	22,178	$395K
95024		3.8%	3,753	3,468	$160K
31231		3.0%	788	779	$128K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	2.6%	1,908	1,866	$110K
94010		2.3%	3,518	3,467	$96K
99244	Office or other outpatient consultation, moderate to high complexity	2.1%	530	526	$89K
95115		1.4%	7,300	3,483	$60K
99205	Prolong outpt/office vis	1.2%	253	250	$51K

19 more codes

31298		1.2%	12	$49K
94060		1.1%	982	$46K
96401		<1%	482	$38K
99215	Doctor's office visit, returning patient (complex)	<1%	216	$33K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	950	$27K
70486		<1%	222	$24K
J2357	Injection, omalizumab, 5 mg	<1%	13	$22K
30140		<1%	53	$15K
99203	Doctor's office visit, new patient (routine)	<1%	165	$15K
95012		<1%	899	$12K
30520		<1%	38	$9K
94664		<1%	749	$8K
92511		<1%	64	$6K
A4617	Mouth piece	<1%	1,223	$5K
99245		<1%	13	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	35	$720.44
90686		<1%	35	$664.15
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	47	$499.72
J3535	Drug administered through a metered dose inhaler	<1%	44	$48.09

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialREED, CECILE (REPRESENTATIVE)

Parent organizationBREATHEAMERICA, INC.